U.S. Earnings Preview: After Market Close May 12

Dow Jones05-13

This article was automatically generated by Dow Jones using technology from Automated Insights.

The following companies are among those expected to report their latest financial results after the market closes.

Resideo Technologies Inc.'s first-quarter EPS is forecast at 60 cents, compared with a loss of 2 cents in the prior-year period. Adjusted EPS is forecast at 61 cents.

Astronics Corp.'s first-quarter EPS is forecast at 32 cents. Adjusted EPS is forecast at 56 cents.

Arteris Inc.'s first-quarter EPS is forecast at a loss of 19 cents, compared with a loss of 20 cents in the prior-year period. Adjusted EPS is forecast at a loss of 7 cents.

PennantPark Floating Rate Capital Ltd.'s second-quarter EPS is forecast at 28 cents, compared with 19 cents in the prior-year period. Adjusted EPS is forecast at 27 cents.

Kura Oncology Inc.'s first-quarter EPS is forecast at a loss of 83 cents, compared with a loss of 66 cents in the prior-year period.

ODDITY Tech Ltd.'s first-quarter EPS is forecast at a loss of 16 cents. Adjusted EPS is forecast at a loss of 3 cents.

Gladstone Investment Corp.'s fourth-quarter EPS is forecast at 22 cents, compared with 49 cents in the prior-year period. Adjusted EPS is forecast at 21 cents.

NeuroPace Inc.'s first-quarter EPS is forecast at a loss of 20 cents, compared with a loss of 21 cents in the prior-year period. Adjusted EPS is forecast at a loss of 23 cents.

B&G Foods Inc.'s first-quarter EPS is forecast at a loss of 14 cents, compared with net income of 1 cent per share in the prior-year period. Adjusted EPS is forecast at 5 cents.

Digimarc Corp.'s first-quarter EPS is forecast at a loss of 36 cents, compared with a loss of 55 cents in the prior-year period.

a.k.a. Brands Holding Corp.'s first-quarter EPS is forecast at a loss of $1.00, compared with a loss of 78 cents in the prior-year period.

MaxCyte Inc.'s first-quarter EPS is forecast at a loss of 8 cents, compared with a loss of 10 cents in the prior-year period.

TELA Bio Inc.'s first-quarter EPS is forecast at a loss of 24 cents, compared with a loss of 25 cents in the prior-year period. Adjusted EPS is forecast at a loss of 18 cents.

TransAct Technologies Inc.'s first-quarter EPS is forecast at 22 cents. Adjusted EPS is forecast at a loss of 8 cents.

Generated from Dow Jones Calendar Live with data from Dow Jones and Factset.

 

(END) Dow Jones Newswires

May 12, 2026 15:31 ET (19:31 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment